{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:16:16Z","timestamp":1780517776471,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s11936-010-0076-7","type":"journal-article","created":{"date-parts":[[2010,4,13]],"date-time":"2010-04-13T04:01:14Z","timestamp":1271131274000},"page":"214-229","source":"Crossref","is-referenced-by-count":37,"title":["Critical Limb Ischemia"],"prefix":"10.1007","volume":"12","author":[{"given":"Andres","family":"Schanzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,14]]},"reference":[{"key":"76_CR1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","volume":"326","author":"MH Criqui","year":"1992","unstructured":"Criqui MH, Langer RD, Fronek A, et al.: Mortality over a period of 10\u00a0years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381\u2013386.","journal-title":"N Engl J Med"},{"key":"76_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1358863X08089277","volume":"13","author":"AT Hirsch","year":"2008","unstructured":"Hirsch AT, Hartman L, Town RJ, Virnig BA: National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 2008, 13:209\u2013215.","journal-title":"Vasc Med"},{"key":"76_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0021-9150(91)90014-T","volume":"87","author":"M McKenna","year":"1991","unstructured":"McKenna M, Wolfson S, Kuller L: The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 1991, 87:119\u2013128.","journal-title":"Atherosclerosis"},{"key":"76_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1067\/mhj.2002.122871","volume":"143","author":"JM Murabito","year":"2002","unstructured":"Murabito JM, Evans JC, Nieto K, et al.: Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002, 143:961\u2013965.","journal-title":"Am Heart J"},{"key":"76_CR5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0741-5214(89)70041-0","volume":"9","author":"MA Howell","year":"1989","unstructured":"Howell MA, Colgan MP, Seeger RW, et al.: Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 1989, 9:691\u2013696; discussion 696\u2013697.","journal-title":"J Vasc Surg"},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","volume":"366","author":"DJ Adam","year":"2005","unstructured":"Adam DJ, Beard JD, Cleveland T, et al.: Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005, 366:1925\u20131934.","journal-title":"Lancet"},{"key":"76_CR7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/01.RVI.0000137978.15352.C6","volume":"15","author":"A Stoyioglou","year":"2004","unstructured":"Stoyioglou A, Jaff MR: Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol 2004, 15:1197\u20131207.","journal-title":"J Vasc Interv Radiol"},{"key":"76_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.297.11.1197","volume":"297","author":"PG Steg","year":"2007","unstructured":"Steg PG, Bhatt DL, Wilson PW, et al.: One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007, 297:1197\u20131206.","journal-title":"JAMA"},{"key":"76_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2261-5-14","volume":"5","author":"J Caro","year":"2005","unstructured":"Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I: The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005, 5:14.","journal-title":"BMC Cardiovasc Disord"},{"issue":"Suppl S","key":"76_CR10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, et al.: TASC II Working Group: Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007, 45(Suppl S):S5\u2013S67.","journal-title":"J Vasc Surg"},{"key":"76_CR11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/SLA.0b013e31814699a2","volume":"246","author":"BG DeRubertis","year":"2007","unstructured":"DeRubertis BG, Faries PL, McKinsey JF, et al.: Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions. Ann Surg 2007, 246:415\u2013422; discussion 422\u2013424.","journal-title":"Ann Surg"},{"key":"76_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jvs.2009.01.035","volume":"50","author":"PP Goodney","year":"2009","unstructured":"Goodney PP, Beck AW, Nagle J, et al.: National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg 2009, 50:54\u201360.","journal-title":"J Vasc Surg"},{"key":"76_CR13","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"AT Hirsch","year":"2006","unstructured":"Hirsch AT, Haskal ZJ, Hertzer NR, et al.: American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC\/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation: ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113:e463\u2013e654.","journal-title":"Circulation"},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/euhj.1998.1194","volume":"20","author":"JF Price","year":"1999","unstructured":"Price JF, Mowbray PI, Lee AJ, et al.: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J 1999, 20:344\u2013353.","journal-title":"Eur Heart J"},{"key":"76_CR15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jvs.2005.11.041","volume":"43","author":"EP Brass","year":"2006","unstructured":"Brass EP, Anthony R, Dormandy J, et al.: Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg 2006, 43:752\u2013759.","journal-title":"J Vasc Surg"},{"key":"76_CR16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group: MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7\u201322.","journal-title":"Lancet"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jvs.2007.01.024","volume":"45","author":"HH Feringa","year":"2007","unstructured":"Feringa HH, Karagiannis SE, van Waning VH, et al.: The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 2007, 45:936\u2013943.","journal-title":"J Vasc Surg"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","volume":"25","author":"M Schillinger","year":"2004","unstructured":"Schillinger M, Exner M, Mlekusch W, et al.: Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 2004, 25:742\u2013748.","journal-title":"Eur Heart J"},{"key":"76_CR19","doi-asserted-by":"crossref","unstructured":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists\u2019 Collaboration. BMJ 1994, 308:81\u2013106.","DOI":"10.1136\/bmj.308.6921.81"},{"key":"76_CR20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71\u201386.","journal-title":"BMJ"},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJM199612053352301","volume":"335","author":"DT Mangano","year":"1996","unstructured":"Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996, 335:1713\u20131720.","journal-title":"N Engl J Med"},{"key":"76_CR22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jvs.2007.11.056","volume":"47","author":"A Schanzer","year":"2008","unstructured":"Schanzer A, Hevelone N, Owens CD, et al.: Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 2008, 47:774\u2013781.","journal-title":"J Vasc Surg"},{"key":"76_CR23","doi-asserted-by":"crossref","unstructured":"Bradbury A, Adam DJ, Bell J, et al.: Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010 (In press).","DOI":"10.1016\/j.jvs.2010.01.077"},{"key":"76_CR24","doi-asserted-by":"crossref","unstructured":"Forbes J, Adam DJ, Bell J, et al.: Bypass versus angioplasty in severe ischemia of the leg (BASIL) trial: health-related quality of life, resource utilization and cost-effectiveness analysis. J Vasc Surg 2010 (In press).","DOI":"10.1016\/j.jvs.2010.01.076"},{"key":"76_CR25","doi-asserted-by":"crossref","unstructured":"Bradbury A, Adam DJ, Bell J, et al.: Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg 2010 (In press). This article discusses long-term follow-up in the BASIL trial by treatment received.","DOI":"10.1016\/j.jvs.2010.01.074"},{"key":"76_CR26","doi-asserted-by":"crossref","unstructured":"Bradbury A, Adam DJ, Bell J, et al.: Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: a description of the severity and extent of disease using the Bollinger angiogram scoring method and the TASC II classification. J Vasc Surg 2010 (In press).","DOI":"10.1016\/j.jvs.2010.01.075"},{"key":"76_CR27","doi-asserted-by":"crossref","unstructured":"Bradbury A, Adam DJ, Bell J, et al.: Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention to treat analysis of amputation free and overall survival in patients randomised to a bypass surgery first or a balloon angioplasty first strategy. J Vasc Surg 2010 (In press). This article discusses long-term follow-up in the BASIL trial by treatment assigned.","DOI":"10.1016\/j.jvs.2010.01.073"},{"key":"76_CR28","doi-asserted-by":"crossref","unstructured":"Conte MS: BASIL and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia. J Vasc Surg 2010 (In press).","DOI":"10.1016\/j.jvs.2010.02.001"},{"key":"76_CR29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/eurheartj\/ehn514","volume":"30","author":"C Kasapis","year":"2009","unstructured":"Kasapis C, Henke PK, Chetcuti SJ, et al.: Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J 2009, 30:44\u201355.","journal-title":"Eur Heart J"},{"key":"76_CR30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.jvs.2008.07.003","volume":"48","author":"MC Stoner","year":"2008","unstructured":"Stoner MC, Defreitas DJ, Manwaring MM, et al.: Cost per day of patency: understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg 2008, 48:1489\u20131496.","journal-title":"J Vasc Surg"},{"key":"76_CR31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","volume":"43","author":"MS Conte","year":"2006","unstructured":"Conte MS, Bandyk DF, Clowes AW, et al.: Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006, 43:742\u2013751; discussion 751.","journal-title":"J Vasc Surg"},{"key":"76_CR32","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jvs.2007.08.012","volume":"46","author":"JL Cronenwett","year":"2007","unstructured":"Cronenwett JL, Likosky DS, Russell MT, et al.: A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 2007, 46:1093\u20131101; discussion 101\u2013102.","journal-title":"J Vasc Surg"},{"key":"76_CR33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jvs.2005.05.001","volume":"42","author":"MS Conte","year":"2005","unstructured":"Conte MS, Bandyk DF, Clowes AW, et al.: Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005, 42:456\u2013464; discussion 464\u2013465.","journal-title":"J Vasc Surg"},{"key":"76_CR34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jvs.2009.02.014","volume":"49","author":"PP Goodney","year":"2009","unstructured":"Goodney PP, Likosky DS, Cronenwett JL: Predicting ambulation status one year after lower extremity bypass. J Vasc Surg 2009, 49:1431\u20139 e1.","journal-title":"J Vasc Surg"},{"key":"76_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.avsg.2009.06.015","volume":"24","author":"PP Goodney","year":"2010","unstructured":"Goodney PP, Nolan BW, Schanzer A, et al.: Factors associated with amputation or graft occlusion 1\u00a0year after lower extremity bypass in northern New England. Ann Vasc Surg 2010, 24:57\u201368.","journal-title":"Ann Vasc Surg"},{"key":"76_CR36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jvs.2009.05.055","volume":"50","author":"A Schanzer","year":"2009","unstructured":"Schanzer A, Goodney PP, Li Y, et al.: Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg 2009, 50:769\u2013775; discussion 775.","journal-title":"J Vasc Surg"},{"key":"76_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jvs.2009.07.123","volume":"51","author":"PP Goodney","year":"2010","unstructured":"Goodney PP, Nolan BW, Schanzer A, et al.: Factors associated with death 1\u00a0year after lower extremity bypass in northern New England. J Vasc Surg 2010, 51:71\u201378.","journal-title":"J Vasc Surg"},{"key":"76_CR38","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.jvs.2007.07.053","volume":"46","author":"LL Nguyen","year":"2007","unstructured":"Nguyen LL, Brahmanandam S, Bandyk DF, et al.: Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg 2007, 46:1191\u20131197.","journal-title":"J Vasc Surg"},{"key":"76_CR39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvs.2007.08.033","volume":"46","author":"A Schanzer","year":"2007","unstructured":"Schanzer A, Hevelone N, Owens CD, et al.: Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007, 46:1180\u20131190; discussion 1190.","journal-title":"J Vasc Surg"},{"key":"76_CR40","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","volume":"50","author":"MS Conte","year":"2009","unstructured":"Conte MS, Geraghty PJ, Bradbury AW, et al.: Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009, 50:1462\u201373.e3.","journal-title":"J Vasc Surg"},{"key":"76_CR41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jvs.2006.07.015","volume":"44","author":"LL Nguyen","year":"2006","unstructured":"Nguyen LL, Moneta GL, Conte MS, et al.: Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 2006, 44:977\u2013983; discussion 983\u2013984.","journal-title":"J Vasc Surg"},{"key":"76_CR42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/CIRCULATIONAHA.108.810341","volume":"119","author":"LL Nguyen","year":"2009","unstructured":"Nguyen LL, Hevelone N, Rogers SO, et al.: Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation 2009, 119:123\u2013130.","journal-title":"Circulation"},{"key":"76_CR43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jvs.2007.07.049","volume":"46","author":"SA Berceli","year":"2007","unstructured":"Berceli SA, Hevelone ND, Lipsitz SR, et al.: Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg 2007, 46:1173\u20131179.","journal-title":"J Vasc Surg"},{"key":"76_CR44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jvs.2005.11.025","volume":"43","author":"M Albers","year":"2006","unstructured":"Albers M, Romiti M, Brochado-Neto FC, et al.: Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006, 43:498\u2013503.","journal-title":"J Vasc Surg"},{"key":"76_CR45","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jvs.2008.07.062","volume":"48","author":"A Schanzer","year":"2008","unstructured":"Schanzer A, Mega J, Meadows J, et al.: Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 2008, 48:1464\u20131471.","journal-title":"J Vasc Surg"},{"key":"76_CR46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/153857440503900102","volume":"39","author":"MS Conte","year":"2005","unstructured":"Conte MS, Lorenz TJ, Bandyk DF, et al.: Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovasc Surg 2005, 39:15\u201323.","journal-title":"Vasc Endovasc Surg"},{"key":"76_CR47","doi-asserted-by":"crossref","unstructured":"Ubbink DT, Vermeulen H: Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 2003, CD004001.","DOI":"10.1002\/14651858.CD004001"},{"key":"76_CR48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jvs.2005.05.051","volume":"42","author":"N Labropoulos","year":"2005","unstructured":"Labropoulos N, Leon Jr LR, Bhatti A, et al.: Hemodynamic effects of intermittent pneumatic compression in patients with critical limb ischemia. J Vasc Surg 2005, 42:710\u2013716.","journal-title":"J Vasc Surg"},{"key":"76_CR49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jvs.2007.11.043","volume":"47","author":"SJ Kavros","year":"2008","unstructured":"Kavros SJ, Delis KT, Turner NS, et al.: Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg 2008, 47:543\u2013549.","journal-title":"J Vasc Surg"},{"key":"76_CR50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/jcb.22315","volume":"108","author":"EB Sneider","year":"2009","unstructured":"Sneider EB, Nowicki PT, Messina LM: Regenerative medicine in the treatment of peripheral arterial disease. J Cell Biochem 2009, 108:753\u2013761.","journal-title":"J Cell Biochem"},{"key":"76_CR51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","volume":"118","author":"RJ Powell","year":"2008","unstructured":"Powell RJ, Simons M, Mendelsohn FO, et al.: Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 2008, 118:58\u201365.","journal-title":"Circulation"},{"key":"76_CR52","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","volume":"16","author":"S Nikol","year":"2008","unstructured":"Nikol S, Baumgartner I, Van Belle E, et al.: Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 2008, 16:972\u2013978.","journal-title":"Mol Ther"},{"key":"76_CR53","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","volume":"108","author":"S Rajagopalan","year":"2003","unstructured":"Rajagopalan S, Mohler 3rd ER, Lederman RJ, et al.: Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003, 108:1933\u20131938.","journal-title":"Circulation"},{"key":"76_CR54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mthe.2002.0638","volume":"6","author":"K Makinen","year":"2002","unstructured":"Makinen K, Manninen H, Hedman M, et al.: Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002, 6:127\u2013133.","journal-title":"Mol Ther"},{"key":"76_CR55","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/hum.2006.17.683","volume":"17","author":"YH Kusumanto","year":"2006","unstructured":"Kusumanto YH, van Weel V, Mulder NH, et al.: Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 2006, 17:683\u2013691.","journal-title":"Hum Gene Ther"},{"key":"76_CR56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, et al.: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427\u2013435.","journal-title":"Lancet"},{"key":"76_CR57","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/eurheartj\/ehi285","volume":"26","author":"K Lenk","year":"2005","unstructured":"Lenk K, Adams V, Lurz P, et al.: Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 2005, 26:1903\u20131909.","journal-title":"Eur Heart J"},{"key":"76_CR58","first-page":"125","volume":"51","author":"G Tepe","year":"2010","unstructured":"Tepe G, Schmitmeier S, Speck U, et al.: Advances on drug-coated balloons. J Cardiovasc Surg (Torino) 2010, 51:125\u2013143.","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"76_CR59","first-page":"C63","volume":"4","author":"B Scheller","year":"2008","unstructured":"Scheller B, Speck U: Potential solutions to the current problem: coated balloon. EuroIntervention 2008, 4:C63\u2013C66.","journal-title":"EuroIntervention"},{"key":"76_CR60","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","volume":"358","author":"G Tepe","year":"2008","unstructured":"Tepe G, Zeller T, Albrecht T, et al.: Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008, 358:689\u2013699.","journal-title":"N Engl J Med"},{"key":"76_CR61","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00270-008-9472-8","volume":"32","author":"M Bosiers","year":"2009","unstructured":"Bosiers M, Peeters P, D\u2019Archambeau O, et al.: AMS INSIGHT\u2014absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009, 32:424\u2013435.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"76_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/05-1674.1","volume":"13","author":"JR Laird","year":"2006","unstructured":"Laird JR, Zeller T, Gray BH, et al.: Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther 2006, 13:1\u201311.","journal-title":"J Endovasc Ther"},{"key":"76_CR63","first-page":"455","volume":"48","author":"M Bosiers","year":"2007","unstructured":"Bosiers M, Deloose K, Verbist J, Peeters P: Nitinol stenting for treatment of \u2018below-the-knee\u2019 critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg 2007, 48:455\u2013461.","journal-title":"J Cardiovasc Surg"},{"key":"76_CR64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jvs.2007.09.018","volume":"47","author":"BG DeRubertis","year":"2008","unstructured":"DeRubertis BG, Pierce M, Ryer EJ, et al.: Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 2008, 47:101\u2013108.","journal-title":"J Vasc Surg"},{"key":"76_CR65","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jvs.2008.02.027","volume":"48","author":"KA Giles","year":"2008","unstructured":"Giles KA, Pomposelli FB, Spence TL, et al.: Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg 2008, 48:128\u2013136.","journal-title":"J Vasc Surg"},{"key":"76_CR66","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jvs.2008.01.005","volume":"47","author":"M Romiti","year":"2008","unstructured":"Romiti M, Albers M, Brochado-Neto FC, et al.: Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008, 47:975\u2013981.","journal-title":"J Vasc Surg"},{"key":"76_CR67","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jvs.2009.02.010","volume":"49","author":"WP Robinson 3rd","year":"2009","unstructured":"Robinson 3rd WP, Owens CD, Nguyen LL, et al.: Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg 2009, 49:1416\u20131425.","journal-title":"J Vasc Surg"},{"key":"76_CR68","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jvs.2007.01.025","volume":"45","author":"CD Owens","year":"2007","unstructured":"Owens CD, Ho KJ, Kim S, et al.: Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg 2007, 45:944\u2013952.","journal-title":"J Vasc Surg"},{"key":"76_CR69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00268-006-0242-y","volume":"31","author":"F Biancari","year":"2007","unstructured":"Biancari F, Salenius JP, Heikkinen M, et al.: Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 2007, 31:217\u2013225; discussion 226\u2013227.","journal-title":"World J Surg"},{"key":"76_CR70","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10016-003-0040-z","volume":"17","author":"PJ Rossi","year":"2003","unstructured":"Rossi PJ, Skelly CL, Meyerson SL, et al.: Redo infrainguinal bypass: factors predicting patency and limb salvage. Ann Vasc Surg 2003, 17:492\u2013502.","journal-title":"Ann Vasc Surg"},{"key":"76_CR71","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1067\/mva.2002.120046","volume":"35","author":"B Toursarkissian","year":"2002","unstructured":"Toursarkissian B, D\u2019Ayala M, Stefanidis D, et al.: Angiographic scoring of vascular occlusive disease in the diabetic foot: relevance to bypass graft patency and limb salvage. J Vasc Surg 2002, 35:494\u2013500.","journal-title":"J Vasc Surg"},{"key":"76_CR72","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1078-5884(98)80179-2","volume":"15","author":"A Alback","year":"1998","unstructured":"Alback A, Biancari F, Saarinen O, Lepantalo M: Prediction of the immediate outcome of femoropopliteal saphenous vein bypass by angiographic runoff score. Eur J Vasc Endovasc Surg 1998, 15:220\u2013224.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"76_CR73","doi-asserted-by":"crossref","unstructured":"Simons J, Goodney PG, Nolan B, et al.: Failure to achieve clinical improvement despite graft patency in patients undergoing lower extremity bypass for critical limb ischemia. J Vasc Surg 2010 (In press).","DOI":"10.1016\/j.jvs.2010.01.083"},{"key":"76_CR74","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jvs.2006.06.015","volume":"44","author":"SM Taylor","year":"2006","unstructured":"Taylor SM, Kalbaugh CA, Blackhurst DW, et al.: Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 2006, 44:747\u2013755; discussion 755\u2013756.","journal-title":"J Vasc Surg"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11936-010-0076-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T06:09:11Z","timestamp":1559023751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-010-0076-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,14]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s11936-010-0076-7","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,14]]}}}